Vim li cas Standardized QC yog qhov tseem ceeb rau Tirzepatide API hauv 2026
Raws li tau piav qhia hauvVim li cas Tirzepatide API Supply Tight hauv 2026?, lub ntiaj teb no tus neeg muag khoom lag luam yog fragmented heev. Tsawg dua 15% ntawm cov neeg muag khoom muaj kev sib xyaw ua ke, ua kom huv thiab hauv -tsev QC labs. Cov neeg muag khoom feem ntau outsource kev sim lossis hloov COA cov ntaub ntawv, ua rau plaub qhov kev poob haujlwm tsis tuaj yeem:
- ± 3% nruab nrab batch purity fluctuation, ua rau unrepeatable nyob rau hauv vitro / nyob rau hauv vivo sim cov ntaub ntawv:
- Kev tshem tawm ntau dhau / truncated impurities uas tsis muaj zog GLP-1 / GIP dual agonist kev ua haujlwm
- Tshaj - txwv tsis pub seem DMF thiab TFA ua rau muaj kev phom sij txaus ntshai hauv kev sim ua ntej
- Tsis tiav traceability ua txhaum txoj cai saib xyuas yuav tsum tau rau FDA / EMA / NMPA IND filing
Cov lus qhia no ua raws li SPPS cov qauv tsim khoom hauvYuav ua li cas Tirzepatide Synthesizedthiab tus neeg muab khoom pov thawj cov qauv hauvYuav Ua Li Cas Xaiv Tirzepatide API Cov Khoom Siv Hauv Suav Teb.
Core Global Regulatory Framework
Tag nrhoTirzepatide API Kev ua haujlwm QC yuav tsum ua raws li plaub tus qauv kev cai thoob ntiaj teb:
- ICH Q2(R1): Kev txheeb xyuas txoj kev siv tau rau HPLC, MS thiab impurity kom muaj nuj nqis ntawm lipidated peptides ntev
- ICH Q3C(R8): ppm txwv rau cov kuab tshuaj organic siv hauv SPPS cleavage thiab HPLC purification
- USP<621> & <736>: Yuav tsum txheeb xyuas thiab purity assay raws tu qauv rau hluavtaws peptide yeeb tshuaj
- FDA 2022 Peptide Sameness Kev taw qhia: Tag nrho cov impurity profile txuam yuav tsum tau rau txhua qhov kev pab cuam tirzepatide biosimilar
12 Yuav Tsum QC Test Panels rau Tsim Nyog Tirzepatide API
Ib qho kev tsim khoom raug cai yuav tsum ua kom tiav tag nrho 12 yam khoom hauv qab no. Ib qho kev xeem uas ploj lawm qhia tus neeg xa khoom raws li kev pheej hmoo siab -.
- Kev tshuaj xyuas qhov tshwm sim (cov xim dawb lyophilized zoo hmoov, tsis muaj xim lossis agglomeration)
- LC-MS puv-scan molecular qhia paub tseeb
- UHPLC tag nrho purity thiab tus kheej muaj feem xyuam rau cov khoom muaj nuj nqis
- Qhov siab tshaj plaws ib qho tsis paub impurity txwv nrhiav kom pom
- GC-FID residual solvent quantitative analysis (ICH Class 2 solvents)
- Karl Fischer ntsuas dej noo
- Net peptide kev ntsuam xyuas
- Ion chromatography acetate counterion nrhiav kom tau
- Kev ntsuas qhov ntsuas qhov ntsuas qhov ntsuas
- Kev ntsuam xyuas hlau hnyav (Pb, As, Cd, Hg; yuav tsum tau kuaj xyuas qib)
- LAL endotoxin quantification
- Tag nrho cov batch traceability hla - pov thawj (cov khoom siv raw, hnub sib xyaw, purification khiav ID)
HPLC/UHPLC Purity & Lwm Yam Tshuaj Ntsuam Xyuas Cov Qauv

HPLC/UHPLC yog qhov tseem ceeb QC ntsuas ntsuas rau tirzepatide. Cov neeg muag khoom tsis kam muab cov khoom nyoos, cov chromatograms tsis tuaj yeem lees paub tias cov neeg muag khoom zais cov txiaj ntsig tsis zoo.
Standard HPLC Test Parameters
Kem: 300Å wide-pore C4 thim rov qab- theem kab (4.6 mm ID)
Ntsuas wavelength: 210nm
Mobile theem: Dej + 0.1% TFA / Acetonitrile + 0.1% TFA gradient elution
Kev sib cais yam tsawg kawg nkaus: 3 rounds ntawm gradient hloov
Official 2026 ICH Impurity Thresholds
| Spec Index | Kev tshawb fawb-Qib | GMP Clinical / Commercial Qib |
|---|---|---|
| Yam tsawg kawg nkaus ncov purity | Ntau dua lossis sib npaug li 98.0% | Ntau dua lossis sib npaug li 98.0% |
| Qhov siab tshaj plaws ib zaug teev impurity | Tsawg dua lossis sib npaug li 0.50% | Tsawg dua lossis sib npaug li 0.10% |
| Tag nrho cov sum ntawm tag nrho cov impurities | Tsawg dua lossis sib npaug li 2.00% | Tsawg dua lossis sib npaug li 1.00% |
| Tso cai batch-rau-batch fluctuation | Tsawg dua lossis sib npaug li 2.0% | Tsawg dua lossis sib npaug li 1.0% |
Loj Spectrometry Identity Confirmation Requirement
Cov ntaub ntawv tsim nyog MS yuav tsum ua tau raws li ob qho qauv nruj:
- Ntsuas monoisotopic molecular qhov hnyav sib tw theoretical tirzepatide tus nqi hauv ± 1 Da
- MS/MS fragment sequencing xyuas kom tiav 39-amino-acid qaum thiab pob txha C20 fatty acid sab saw
Kev tshawb fawb-Qib vs GMP Clinical-Qib Specification piv
| QC Test Yam khoom | Kev tshawb fawb-Qib (Early R&D / In Vitro Screening) | GMP Clinical{0}}Qib (Preclinical / IND / Biosimilar ANDA) |
|---|---|---|
| Maximum ib qho impurity cap | Tsawg dua los yog sib npaug li 0.5% | Tsawg dua lossis sib npaug li 0.1% |
| Cov ntaub ntawv residual hnyav | Cov ntsiab lus tseem ceeb nkaus xwb | Ua kom tiav GC chromatogram nrog kev sib koom ua ke siab kawg |
| Kev kuaj Endotoxin | Xaiv tau | Yuav tsum tau, Tsawg dua los yog sib npaug rau 0.5 EU / ml |
| Heavy hlau ntes | Tsis xav tau | Yuav tsum tau rau USP<232> |
| Accelerated stability ntaub ntawv | Tsis xav tau | Daim ntawv qhia txog kev ruaj ntseg 6 lub hlis |
| Batch ntau lawm cov ntaub ntawv | Basic ntau tus lej xwb | Tag nrho raw khoom, synthesis thiab purification cav |
| Cov ntaub ntawv kos npe | Generic digital stamp | Tes- kos npe rau QA tus thawj tswj daim ntawv pov thawj |
| Thib peb-kev xeem | Yeem xaiv ua ntej kev txiav txim ntau | Yuav tsum tau rau kilogram- qib kev txiav txim kho mob |
Kauj ruam-los ntawm-Step Authentic Tirzepatide COA Verification

Standard COA Validation cov kauj ruam
- Hla - xyuas COA batch naj npawb tiv thaiv cov khoom vial daim ntawv lo; xoom deviation tso cai
- Thov thawj PDF HPLC thiab MS spectrogram cov ntaub ntawv, tsis compressed screenshots
- Paub meej tias tag nrho 12 qhov yuav tsum tau xeem cov khoom ntawm Tshooj 3 muaj cov txiaj ntsig tshwj xeeb
- Txheeb xyuas tus neeg sau ntawv QA tus thawj coj kos npe thiab raug GMP Hoobkas foob
- Sib piv cov residual solvent qhov tseem ceeb tiv thaiv ICH Q3C sab sauv txwv
Sab saum toj 10 Fake COA Red Flags
- Tsis kam xa cov ntaub ntawv kuaj xyuas HPLC/MS uas tsis tau kho
- purity qhov tseem ceeb yog tsau cov lej (99.00%, 98.00%) uas tsis muaj qhov hloov pauv ntawm tus lej lej
- Cov lej ntawm COA thiab cov khoom ntim khoom tsis sib xws
- Tsis nco qab cov kuab tshuaj residual, noo noo lossis peptide cov ntsiab lus tshwm sim
- Hnub kuaj yog ntxov tshaj hnub tsim khoom
- Tsis muaj npe QA kos npe lossis GMP lub Hoobkas
- Cov qauv zoo ib yam COA siv rau tag nrho cov khoom tsim khoom
- HPLC chromatogram tsis muaj daim ntawv sau npe, kev sib xyaw ua ke impurity peaks
- MS molecular hnyav deviates ntau tshaj 1 Da los ntawm tus nqi theoretical
- Tsis muaj QR code lossis tus lej cim tshwj xeeb rau kev txheeb xyuas online batch
4 Yam Tseem Ceeb SPPS Impurities & Experimental Risks

Tirzepatide's 39-amino-acid caj qaum tsim plaub pawg loj impurity thaum lub sij hawm Fmoc SPPS synthesis. Cov neeg tsim khoom tsis muaj ntau-pab HPLC purification xa cov khoom tsis zoo uas ua rau qhov kev puas tsuaj tsis zoo:
- Kev tshem tawm ib ntus impurities: Txo GLP-1 / GIP binding affinity, ua rau inconsistent hauv vivo PK cov ntaub ntawv
- Txiav peptide fragments: Tsim tawm - lub hom phiaj receptor binding signals, cuam tshuam nrog kev tswj xyuas pawg
- Oxidation & deamidation degradants: Accelerate API degradation, luv lub neej txee
- Residual organic solvents (TFA/DMF): Cytotoxic rau cell kab, induce siab toxicity outliers nyob rau hauv cov tsiaj sim
Integrated GMP manufacturers nrog nyob rau hauv - tsev npaj HPLC tswj tag nrho plaub hom impurity nyob rau hauv kev cai txwv.
Thib peb -Party Test Workflow & 2026 Tus nqi ntsuas
Standard Test Workflow
- Yuav 50-200 mg qauv kuaj los ntawm lub hom phiaj tus neeg muag khoom
- Qhov muag tsis pom - cov qauv ntawv sau npe yam tsis tau nthuav tawm cov ntaub ntawv xa khoom
- Xa tag nrho lub vaj huam sib luag: HPLC purity, MS tus kheej, residual hnyav, noo noo, endotoxin
- Compare third-party results against supplier COA; >0.1% purity sib txawv=siab - cov khoom raug mob
- Tsuas yog tso cai rau kilogram txiav txim tom qab txhua qhov ntsuas tau raws li cov qauv
2026 Kev Siv Nyiaj Thoob Ntiaj Teb
Kev tshawb fawb tag nrho-qib QC vaj huam sib luag (HPLC + MS): $380–$550 ib tus qauv
Tag Nrho GMP kev tswj xyuas vaj huam sib luag (tag nrho 12 yam khoom): $ 900– $ 1,300 ib qho qauv
3-hli kev ntsuas kev ruaj ntseg: $ 2,200- $ 2,800 ib pob
Tus neeg muag khoom QC Daim Ntawv Teev Npe
Siv daim ntawv tshuaj ntsuam xyuas tus qauv no thaum lub sijhawm yees duab lossis ntawm - kev tshuaj xyuas qhov chaw kom tshem tawm sai sai - cov neeg muag khoom pheej hmoo:
| Kuaj xyuas | Pass / Fail Standard |
|---|---|
| Hauv -Lub Tsev QC Hardware | Nruab nrog ywj pheej UHPLC, LC-MS, GC-FID thiab Karl Fischer cov cuab yeej; tsis muaj outsourced kev kuaj niaj hnub |
| HPLC Kev Tswj Xyuas Zoo | Muab ua tiav, ncov -kev sib xyaw ua ke ntawm HPLC chromatograms rau txhua pawg ntawm kev thov |
| Kev tswj hwm impurity | Ib qho impurity ruaj khov tswj tsawg dua lossis sib npaug li 0.1% rau tag nrho GMP-qib tirzepatide batch |
| COA Management | Cov teeb meem kos npe tag nrho, ua kom tiav COA rau txhua qhov khoom xa tuaj |
| Batch Traceability | Muab tag nrho cov ntaub ntawv raw, synthesis thiab purification batch cov ntaub ntawv ntawm kev thov |
| Independent Test Policy | Txais qhov muag tsis pom qhov thib peb -kev kuaj tus qauv ua ntej kev txiav txim loj loj |
| Batch Consistency | Purity fluctuation hla 3 pawg sib law liag khaws cia li tsawg dua lossis sib npaug li 1% |
| Kev Txhawb Nqa | Muab cov kev tshuaj xyuas tag nrho -npaj QC cov ntaub ntawv rau IND thiab ANDA ua ntaub ntawv |
HDM BIO's ICH-Ua raws li hauv-Lub Tsev QC System

HDM BIO ua haujlwm ywj pheej GMP- ua raws QC lub chaw soj nstuam tau ua tiav nrog txhua tus qauv ICH hauv phau ntawv qhia no:
- Dedicated ntev -peptide UHPLC kab nrog customized 300Å C4 kab optimized rau lipidated tirzepatide
- LC-MS/MS tag nrho fragment sequencing rau txhua pawg ntau lawm
- Tiag -time GC residual kuab tshuaj xyuas tom qab cleavage thiab lyophilization
- Yuav tsum tau kuaj LAL endotoxin rau txhua qhov ntau dua lossis sib npaug rau 98% GMP- qib xa khoom
- Kev ruaj ntseg digital batch QC archive nrog cim QR code traceability ntawm txhua COA
- Proprietary optimized SPPS thev naus laus zis txwv batch - rau -batch purity variation kom tsawg dua lossis sib npaug li 1%
Txhua HDM BIO tirzepatide batch ships nrog tag nrho QC pob: kos npe COA, thawj HPLC chromatogram, MS spectrum, residual solvent GC daim ntawv qhia thiab batch manufacturing trace cov ntsiab lus, tag nrho raws li kev cai thoob ntiaj teb kev xa.
FAQ
Q1: Puas yog 99% purity tirzepatide API ib txwm zoo dua 98%?
A: Tsis yog. Ua kom tiav pob tshab impurity profileing teeb meem ntau dua li ib tus lej sib npaug. Ntau tus neeg muag khoom tshem tawm cov impurity peaks los ntawm kev sib koom ua ke rau cov ntawv cuav 99% purity. Tsim nyog 98% cov ntaub ntawv nrog cov ntawv sau tag nrho impurities xa ntau dua cov txiaj ntsig rau kev tshawb fawb.
Q2: Cov ntaub ntawv QC dab tsi yog qhov yuav tsum tau ua rau IND ua ntaub ntawv?
A: Ua kom tiav COA kos npe, raw HPLC/UHPLC chromatograms, tag nrho LC-MS spectrograms, residual solvent GC cov ntaub ntawv, cov ntaub ntawv noo noo, endotoxin daim ntawv qhia thiab 6-hli ceev ceev cov ntaub ntawv stability. Cov tuam txhab lag luam tsis tuaj yeem muab tag nrho cov kev tshuaj xyuas-npaj pob no.
Q3: Yuav ua li cas pom cov neeg muag khoom zais cov qib impurity tsis ruaj khov?
A: Thov COAs los ntawm peb pawg sib law liag thiab sib piv purity thiab ib qho impurity tus nqi. Kev hloov pauv ntau dua ± 2% lees paub qhov kev tsim khoom tsis zoo thiab kev lim dej tawm.
Q4: Puas yog txhua tus neeg muab khoom tirzepatide muab thawj MS spectra nrog COA?
A: Tsawg dua 15% ntawm cov neeg muag khoom online muab tag nrho cov ntaub ntawv raw spectrometry raw. Cov neeg muag khoom feem ntau tsuas yog txuas tau yooj yim ib zaug xwb -COA muaj nuj nqis yam tsis muaj kev txheeb xyuas tus kheej.
Q5: Vim li cas thiaj li nyob hauv - tsev npaj HPLC muaj peev xwm txuas nrog QC kev ua tau zoo?
A: Tirzepatide yuav tsum muaj tsawg kawg yog 3 qhov sib cais ntawm kev sib cais kom tshem tawm cov impurities zoo sib xws. Cov neeg tsim khoom lag luam tawm kev ua kom huv huv poob tiag - lub sij hawm impurity saib xyuas.
Related Internal Reading
Phau Ntawv Qhia Txog Cov Tub Ntxhais Kawm: Yuav Ua Li Cas Tirzepatide Synthesized: Fmoc SPPS Mechanism Piav Qhia Ib Kauj Ruam
Supply Chain Analysis: Vim Li Cas Tirzepatide API Supply Tight hauv 2026? Ntiaj teb no Manufacturing Bottleneck piav qhia
Sourcing Audit Manual: Yuav Ua Li Cas Xaiv Tirzepatide API Tus Tswv Cuab Hauv Suav Teb (2026 Tus Neeg Yuav Qhia)
Kawg Takeaways
Hauv xyoo 2026 tirzepatide mov tsis txaus, tus qauv ICH GMP kev tswj xyuas zoo yog qhov zoo tshaj plaws kev pheej hmoo txo cov cuab yeej. Tsis txhob xaiv cov khoom siv raw raws li tus nqi qis lossis xa khoom sai. Ib txwm ua kom tiav HPLC/MS cov ntaub ntawv pov thawj, COA kev kuaj xyuas qhov tseeb thiab qhov muag tsis pom qhov thib peb -kev kuaj xyuas tog ua ntej muab kev txiav txim ntau. Ua ntej GMP cov tuam txhab ua ke nrog kev ywj pheej tag nrho - ua haujlwm QC labs kom zoo ib yam, taug qab, kev tswj hwm-npaj tirzepatide API.
Yog tias koj xav tau ICH-raws li tirzepatide API nrog cov ntaub ntawv QC ua tiav, hu rau HDM BIO's QA pab pawg kom thov cov qauv COA thiab teem caij mus ntsib virtual GMP QC lab.





